LUCONAC EXTERNAL SOLUTION FOR NAILS 5% ww

Țară: Singapore

Limbă: engleză

Sursă: HSA (Health Sciences Authority)

Ingredient activ:

Luliconazole

Disponibil de la:

ZUELLIG PHARMA PTE. LTD.

Codul ATC:

D01AC18

Forma farmaceutică:

SOLUTION

Compoziție:

Luliconazole 5% w/w

Calea de administrare:

TOPICAL

Tip de prescriptie medicala:

Prescription Only

Produs de:

Sato Pharmaceutical Co., Ltd. Kazusa Akademia Factory

Statutul autorizaţiei:

ACTIVE

Data de autorizare:

2022-02-14

Caracteristicilor produsului

210.0
表
天
品
名 ルコナック
（シンガポール向け）
制作日
MC
2022.5.11
C
本コード
校
作業者印 AC
仮コード
0307Y02213581
2 校
米
田
色
調
スミ
トラップ
（
）
角度
tgmf6
APP.TB
297.0
LUCONAC
®
,
EXTERNAL
SOLUTION FOR NAILS 5% W/W
Therapeutic agent for tinea unguium
(Luliconazole Solution)
Storage
Store 
at 
or 
below 
30 ℃ 
in 
an 
airtight 
container  away  from  light  and  store  away 
from fire
Expiration 
date
Indicated on the package and container
CONTRAINDICATION
(LUCONAC
® , EXTERNAL SOLUTION FOR
NAILS 5% W/W IS CONTRAINDICATED IN THE FOLLOWING PATIENTS)
Patients 
with 
a 
past 
history 
of 
hypersensitivity 
to 
any 
of 
the 
ingredients of LUCONAC
®
 , External Solution for Nails 5% w/w.
COMPOSITION AND PRODUCT DESCRIPTION
Brand name
LUCONAC
®
, External Solution 
for Nails 5% w/w
Active ingredient/
Content (in 1 g)
Luliconazole 50 mg
Inactive ingredients
_N_
-methyl-2-pyrrolidone, benzyl alcohol, 
diisopropyl adipate, lactic acid, povidone, 
anhydrous ethanol
Product description
A  clear  and  slightly  yellowish  solution  with  a 
characteristic odor
INDICATION

Dermatophyte (
_Trichophyton_
 spp.)

As topical treatment in adult patients with mild to moderate tinea 
unguium 
with 
symptoms 
of 
distal 
and 
lateral 
subungual 
onychomycosis

1.   
LUCONAC
®
, External Solution for Nails 5% w/w should be used 
in patients with a confirmed diagnosis of tinea unguium based on 
the results from direct microscopy or culture, etc.
2.   The  efficacy  and  safety  of  LUCONAC
®
,  External  Solution  for 
Nails  5%  w/w  have  not  been  established  in 
severe  patients  (See 
"CLINICAL�